Evidence-Based Coverage Decisions? Primum Non Nocere
Newell E. McElwee(Capital Group (United States)), Shuk-Mei Ho(Capital Group (United States)), Kimberly A. McGuigan(Capital Group (United States)), Mark Horn(Capital Group (United States))
Cited by 2
Abstract
Drug class reviews are blunt tools for medical decision making. The practice of evidence-based medicine is far more than simply systematic reviews: The patient and doctor are integral. Here we highlight areas of evidence-based coverage decision making where greater balance and transparency could serve to improve the current process, and we recommend elements of a more positive approach that could optimize patient outcomes under resource constraints.
Related Papers
No related papers found
Powered by citation graph analysis